Global X Aging Population ETF (AGNG)
Summary
AGNG Chart
3 Longevity ETFs to Buy and Hold (and Hold)
Longevity is, increasingly, a big business. Advances in healthcare technology and AI have prompted both prominent medical professionals and individual investors to imagine how people might live longer, healthier lives.
Global X Aging Population ETF Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 John Flavin Aspire Capital Advisors LLC | 64,799 | $2.31M | $2.35M | $42,119.35 | 1.83% |
 Bepin Serraj Richard W. Paul & Associates LLC | 17 | $476.96 | $627.64 | $150.68 | 31.59% |
| SML Sweeney & Michel LLC SWEENEY & MICHEL, LLC | 5,853 | $212,261 | $215,302.6 | $3,041.6 | 1.43% |
 Christopher C. Powers Farther Finance Advisors, LLC | 6,757 | $241,220.41 | $248,046.77 | $6,826.36 | 2.83% |
 Cynthia Schlanger Ashton Thomas Private Wealth, LLC | 352 | $12,531 | $12,950.08 | $419.08 | 3.34% |
Global X Aging Population ETF (AGNG) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Global X Aging Population ETF ever had a stock split?
Global X Aging Population ETF Profile
| NASDAQ (NMS) Exchange | US Country |
Overview
The fund is dedicated to investing more than 80% of its total assets in the securities of its underlying index, which is strategically focused on companies that support or benefit from the demographic shift towards longer average life spans and the aging global population. This investment focus takes into account developed market enterprises that are pioneering or significantly contributing to fields such as biotechnology, medical devices, pharmaceuticals, senior living facilities, and specialized healthcare services. Through this targeted investment approach, the fund aims to tap into the growing demand and expanding market opportunities generated by global demographic trends.
Products and Services
- Biotechnology Investments
Allocations in companies engaged in biological and medicinal product development. These firms are at the forefront of creating treatments and solutions that address age-related conditions and diseases, leveraging biotechnological advancements.
- Medical Devices
Investments in innovators and manufacturers of medical devices that play crucial roles in the diagnosis, treatment, and management of health conditions predominately affecting older populations. This includes devices for mobility assistance, monitoring, and surgical interventions.
- Pharmaceuticals
Funding allocated to companies involved in the research, development, and production of medications that cater to the health needs of an aging demographic. This spans a range of therapeutic areas closely linked to age-related diseases.
- Senior Living Facilities
Investment in entities that operate facilities offering specialized living environments for the elderly. These could range from independent living communities to full-assistance nursing homes, focusing on providing care tailored to senior citizens.
- Specialized Health Care Services
Capital directed toward companies providing health care services uniquely designed for the elderly. This encompasses home health care services, rehabilitative therapies, and palliative care, all integral to supporting the well-being of the aging population.
